Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance ...
Ferring Pharmaceuticals announces that nadofaragene firadenovec-vncg (ADSTILADRIN ®) has been upgraded to a National Comprehensive Cancer Network® (NCCN®) Category 2A recommended option for the ...
NVIDIA NeMo Evaluator -- Model Diagnosis & Validation: Hirundo's diagnosis layer uses NeMo Evaluator to automatically benchmark LLMs before and after unlearning across safety and utility metrics, ...
This week, Russian hacker OpSec failure, Interpol helped disrupt 45,000 malicious IPs, the FBI is looking for an ATM ...
Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...
Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...
Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...
Belief BioMed (BBM) today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially ...
Vector Informatik has released VectorCAST 2026, the latest version of its embedded software test automation platform, introducing an AI-powered Requirements Based Test Creator. The new functionality ...
AI Security Fabric platform becomes the first solution purpose-built to enforce all four layers of the Gartner AI TRiSM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results